跳至主要内容
临床试验/CTRI/2021/02/031146
CTRI/2021/02/031146尚未招募2/3 期

Comparative clinical trial to evaluate the efficacy of Baladi Ghritamanda Nasya and Ksheerabala Taila Nasya in the Management of Vataj Shirashoola

Sane guruji Arogya Kendra1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2021年1月3日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
入组人数
80
试验地点
1
主要终点
A clinical study to evaluate efficacy of Baladi Ghritamanda Nasya in Vataj Shirashoola w.r.t. Headache.

研究概览

简要总结

This study is open labelled randomised comparative clinical trial to evaluate the effect of Baladi Ghritamanada Nasya 2 drops in each nostril once a day for 7 days in comparison with Ksheerabala Taila Nasya given same as Baladi Ghritamanda Nasya in Vataj Shirashoola w.r.t. Headache. The primary outcome will be effect of Baladi Ghritamanda Nasya and Secondary outcome will be comparison between trial drug and control drug in the management of Vataj Shirashoola w.r.t. Headache.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • patients suffering from symptoms of Vataj Shiashoola i.e. Shankha Ativedana, Bhru Ativedana, Lalat Ativedana 2)patients of age group 20 to 60 yrs 3)patients of eiter gender will be included in the study 4)patients yogya for Nasyakarma.

排除标准

  • patients suffering from Sinusitis,systemic disorder like Hypertension, Diabetes, 2)Secondary Headache caused by Meningitis, Tumour, Encephalitis 3)Pregnancy and Lactation.

结局指标

主要结局

A clinical study to evaluate efficacy of Baladi Ghritamanda Nasya in Vataj Shirashoola w.r.t. Headache.

时间窗: The drug will be given for 7 days.patient will be assessed before and after treatment.Total duration of study will be 18 months.

Subjective Parameters(by using grades and Visual analogue Scale)-Shankha Ativedana,Bhru Ativedana,Lalat Ativedana

时间窗: The drug will be given for 7 days.patient will be assessed before and after treatment.Total duration of study will be 18 months.

Other subjective parameters-Severity of headache, Frequency of headache,Duration of headache

时间窗: The drug will be given for 7 days.patient will be assessed before and after treatment.Total duration of study will be 18 months.

次要结局

  • Comparision between efficacy of Baladi Ghritamanda Nasya and Ksheerabala Taila Nasya in Vataj Shirashoola w.r.t. Headahe.(Total duration of study will be 18 months)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验